Advertisement

Topics

Companies Related to "Efficacy of Treatment for Panic Disorder" [Most Relevant Company Matches] RSS

01:57 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Efficacy of Treatment for Panic Disorder" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Treatment Panic Disorder" Companies 1–25 of 3,600+

Extremely Relevant

Zoloft

Zoloft is well tolerated and effective for the treatment of depression and certain types of anxiety disorders. Zoloft is FDA approved to treat depression, social anxiety disorder, posttraumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD) in adults over age 18. It is also approved for OCD in children and adolescents age 6-1...


Relevant

Pharmacology Research Institute

PRI is an internationally recognized research organization with expertise in pharmacological and multidisciplinary research. Our staff is experienced in the fields of psychiatry, cardiology, rheumatology, family practice, neurology, ophthalmology, gerontology, pharmacoeconomics and quality of life measures.Diagnostic categories treated have included adult attention deficit hyperactivity disorders ...

Clinical Insights

Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become the gold standard in psychopharmacological clinical trials. Our Principal Investigator, Lawrence W. Adler, MD, has participated in the conduct of numerous clinical trials in psychiatric disorders since...


MP Biomedicals

MP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality.Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic visio...

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. ...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. We have five product candidates in clinical trials addressing therapeutic indications with significant unmet needs. Our product candidate for insomnia is currently in Phase III clinical trials and o...

Galleon Pharmaceuticals

Galleon is the first pharmaceutical company to focus primarily on the drug treatment of breathing-control disorders. Its initial goals are to improve the safety, efficacy and economics associated with the acute care of surgical patients and longer-term care of patients with conditions such as moderate-to-severe pain or sleep apnea. In the United States alo...

California Ear Institute

Founded in 1968 as the first practice to be dedicated solely to Hearing Health care in the United States, The California Ear Institute has provided more than a quarter of a million visits for patients with Surgical, Medical, Hearing Aid, Cochlear Implant, Facial Nerve Disorder and Cranial Base Disorder needs. CEI is Northern California’s premier site for treatment of ear related disorders and is...

The Emily Program

The Emily Program was founded in 1993 by Dirk Miller, PhD, LP, after his sister Emily recovered from an eating disorder. To date, The Emily Program has provided more than 4,500 clients with comprehensive treatment for eating disorders. Recognizing that one size does not fit all, The Emily Program develops a personalized care plan for its patients that inco...

Eating Disorder Center of Denver

Established in 2001, Eating Disorder Center of Denver (EDCD) is one of the nation's foremost centers for the diagnosis and treatment of the full range of eating disorders. EDCD is committed to empowering individuals 18 years of age and older suffering with anorexia, bulimia, binge eating and related disorders to help them achieve and sustain recovery. A mu...

TONIX Pharmaceuticals, Inc.

TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system (CNS). The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX re-engineers known pharmaceutical agents to design drugs wi...

H. Lundbeck A/S

We are a research-based company. We engage in research to find new drugs for treatment of CNS disorders, includ­ing depression, schizophrenia, Alzheimer’s disease and Parkinson’s disease.These are serious disorders. They affect not only patients, but also their families and friends. Besides the stress of having a CNS disorder, patients are often exposed to prejudice because, in many sections ...

Q-BIO gene

Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic vision to expand from California into Russia and China, placing ICN in a position to take advantage of the emerging world economy in the new millennium.In 2002, Mr. Panic stepped down as chairman and chief executive officer of ICN Pharmac...

Timberline Knolls Residential Treatment Center

Timberline Knolls is a leading private residential treatment center for eating disorders and substance abuse, with or without trauma, a dual diagnosis or cooccurring disorder. Expert treatment staff offers a nurturing environment of recovery for women and girls (ages 12 and older) on a wooded 43-acre campus in suburban Chicago. Women and families seeking Christian treatment have the option of work...

Sturge-Weber Foundation

Since its founding in 1987, the Sturge-Weber Foundation (SWF) has provided information, education and friendly support to adults and families of children with Sturge-Weber syndrome, a neurological disorder characterized by a facial port wine birthmark and often seizures and glaucoma. In 1992, the SWF expanded its outreach to include Klippel-Trenaunay (KT),...

AveXis, Inc.

AveXis is a clinical-stage gene therapy company establishing unique industry alliances to create innovative treatments in areas of unmet medical needs. The company’s most advanced product candidate, ChariSMA, is in a fully-enrolled Phase 1 clinical trial for the treatment of spinal muscular atrophy (SMA), an autosomal-recessive genetic disorder charac...

Recovery Centers of America (RCA)

Recovery Centers of America offers diverse, comprehensive, and customizable behavioral health management solutions. In an industry in need of serious improvement, RCA has assembled the top experts in the field to collaborate with leadings minds in substance use disorder treatment in updating treatment technology. At each of its centrally located treatment ...

Accelerated Cure Project for Multiple Sclerosis

MS is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the United States and two million individuals worldwide. The disorder occurs twice as often in wom...

Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept’s product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targace...

Greenbrook TMS Inc.

Operating through 47 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with...

The Moore Center

The Moore Center is the longest-established eating disorder treatment facility in Washington state and has been dedicated to treating patients with eating disorders for more than two decades. Founded in 1991 and located in Bellevue, The Moore Center is a regional referral center; providing specialized and comprehensive treatment for eating disorders. The m...

CNS Network

CNS Network, Inc is dedicated to furthering the knowledge and application of psychiatric medications. We perform trials investigating the efficacy of medications for depression, schizophrenia, bipolar disorder, anxiety and Alzheimer's disease. CNS Network, Inc offers a professional staff including physicians, psychologist, nurses, study coordinators and master level clinicians committed to conduct...

Pear Therapeutics, Inc.

Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of produc...

Allergy Immuno Technologies Incorporated

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a clinical reference laboratory at 1527 Monrovia Avenue, Newport Beach, CA, for allergy and other diagnostic testing services for physicians, other laboratories and pharmaceutical companies. As a resul...

Janssen Pharmaceuticals

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, N.J. and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently markets prescription medications for the treatment of schizophrenia, bipolar mania and the treatment of symptoms associated with autistic disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc. is a membe...


More From BioPortfolio on "Efficacy of Treatment for Panic Disorder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks